Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KDM4C is a histone demethylase that specifically removes methyl groups from H3K9me2/3 and H3K36me2/3, influencing gene expression and chromosome segregation. It plays a role in cancer development and progression, making it a potential therapeutic target.
Inhibition of histone demethylase activity by blocking the JmjC catalytic domain or disrupting protein-protein interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysine-specific demethylase 4C (KDM4C).